| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b65747ed78f05dd9ebe107b50ce2855 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 |
| filingDate |
2010-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d27cec05992ac1bb5a202c6c04ec8d5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a701356fa21c9fb95c037acbd14d1548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_101ce5b910e2fb2d366e1055b4882adf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c2e2cbc4f659b17892682730fddc646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c8fed24d8363b51b9cb544df67d1b4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7c40df07819a4b1a606b50b869cefbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04662734022bd100c7b2f0fbb8bf148f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37a6f416e515996d710da9fa1e878770
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bbb7cf0fc96212e36b0cc900a412a88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_447debb0816f7f4e618066392194c2b8 |
| publicationDate |
2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102471337-B |
| titleOfInvention |
Triazolopyridine compounds and their effects as prolyl hydroxylase inhibitors and inducers of erythropoietin production |
| abstract |
The present invention provides triazolopyridine compounds having prolyl hydroxylase inhibitory activity and erythropoietin production inducing ability. The present invention relates to a compound represented by the following general formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a prolyl hydroxylase inhibitor or erythropoietin production inducer containing the compound, Each symbol is as defined in the specification. The compounds of the present invention show prolyl hydroxylase inhibitory action and erythropoietin production inducing ability and are useful as preventive or therapeutic drugs for various diseases and conditions (disorders) caused by reduction of erythropoietin production. |
| priorityDate |
2009-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |